Wound Care (Pharmacies) - Portugal

  • Portugal
  • Revenue in the Wound Care market is projected to reach US$10.87m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.27%, resulting in a market volume of US$10.99m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.06 are generated in 2024.

Key regions: South Korea, United States, Canada, United Kingdom, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Portugal is experiencing significant growth and development.

Customer preferences:
In recent years, there has been a growing demand for wound care products in Portugal. Customers are increasingly seeking out products that are effective in treating wounds and promoting healing. They are also looking for products that are easy to use and convenient to purchase. As a result, there has been a rise in the popularity of wound care products available in pharmacies, as customers can easily access these products and receive professional advice from pharmacists.

Trends in the market:
One of the key trends in the Wound Care (Pharmacies) market in Portugal is the increasing availability of advanced wound care products. These products are designed to provide more effective and efficient wound healing, compared to traditional wound care products. Advanced wound care products, such as hydrogels, foam dressings, and antimicrobial dressings, are gaining traction in the market, as they offer benefits such as improved moisture management, enhanced wound healing, and reduced risk of infection. Another trend in the market is the growing focus on wound care products that are suitable for specific types of wounds. Different types of wounds require different approaches to treatment, and customers are becoming more aware of this. As a result, there is a demand for wound care products that are specifically designed for chronic wounds, surgical wounds, and diabetic foot ulcers, among others. Manufacturers are responding to this demand by developing specialized products that cater to these specific needs.

Local special circumstances:
Portugal has a rapidly aging population, which is contributing to the growth of the Wound Care (Pharmacies) market. Older individuals are more prone to developing chronic wounds, such as pressure ulcers and leg ulcers, which require ongoing wound care. As the elderly population continues to increase, there is a greater need for wound care products in the country. In addition, Portugal has a well-established healthcare system that provides universal access to healthcare services. This has led to an increase in the number of people seeking medical treatment, including wound care, which has further fueled the demand for wound care products in pharmacies.

Underlying macroeconomic factors:
The Wound Care (Pharmacies) market in Portugal is also influenced by macroeconomic factors. The country has experienced steady economic growth in recent years, which has resulted in increased disposable income among consumers. This has allowed individuals to spend more on healthcare products, including wound care products. Furthermore, the government in Portugal has implemented policies to promote the use of generic drugs, which has led to a decrease in the prices of pharmaceutical products, including wound care products. This has made wound care products more affordable and accessible to a wider range of customers. Overall, the Wound Care (Pharmacies) market in Portugal is developing due to increasing customer preferences for effective and convenient wound care products, the availability of advanced wound care products, the focus on specialized wound care products, the aging population, the well-established healthcare system, and the underlying macroeconomic factors.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)